D61.82
Myelophthisis
Clinical Classification Guidelines
Inclusion Terms
- Leukoerythroblastic anemia
- Myelophthisic anemia
- Panmyelophthisis
Excludes Type 1
- idiopathic myelofibrosis (D47.1)
- myelofibrosis NOS (D75.81)
- myelofibrosis with myeloid metaplasia (D47.4)
- primary myelofibrosis (D47.1)
- secondary myelofibrosis (D75.81)
Code Also
- the underlying disorder, such as:
- malignant neoplasm of breast (C50.-)
- tuberculosis (A15.-)
Medical Intelligence & Overview
Myelophthisis is a serious medical condition where the bone marrow, which is responsible for producing blood cells, is infiltrated or replaced by abnormal cells or substances. This replacement disrupts normal blood cell production, leading to anemia, increased risk of infections, and bleeding. The condition is also known as leukoerythroblastic anemia, myelophthisic anemia, or panmyelophthisis, highlighting its impact on various blood cell lines. Recognizing the signs of myelophthisis is essential for timely diagnosis and management.
Causes & Symptoms
Clinical Causes: Metastatic cancers spreading to the bone marrow, such as breast, prostate, or lung cancers Primary bone marrow cancers, including leukemia and lymphoma Aplastic anemia or other marrow failure syndromes Infections that infiltrate the bone marrow, like tuberculosis or fungi Myelodysplastic syndromes or other blood disorders Exposure to certain toxins or radiation leading to marrow infiltration
Key Symptoms: Fatigue and weakness due to anemia Easy bruising or bleeding tendencies Frequent infections because of low white blood cell count Bone pain or tenderness, especially in the ribs or pelvis Paleness of skin and mucous membranes Rapid heartbeat or shortness of breath Unintentional weight loss Fever without obvious cause Swelling or fullness in the abdomen from enlarged spleen or liver
Diagnostic & Treatment
Diagnosis Path: Complete blood count (CBC) showing anemia, low white blood cells, and low platelets Peripheral blood smear revealing immature blood cells and abnormalities Bone marrow biopsy and aspiration to identify infiltration by abnormal cells or substances Imaging studies such as X-rays, MRI, or CT scans to detect bone lesions or metastases Additional tests like cytogenetics or molecular studies to determine underlying causes
Treatment Protocols: Addressing the primary disease, such as chemotherapy or targeted therapy for cancers Supportive care including blood transfusions to manage anemia Growth factors, like erythropoietin or colony-stimulating factors, to stimulate blood cell production Treating infections promptly with antibiotics or antifungals Managing bleeding risks with medications or therapies In some cases, stem cell transplants may be considered for eligible patients Symptom management to improve quality of life
Clinical Advice & FAQs
Billing Guidance
Is D61.82 a billable ICD-10 code?
Yes, D61.82 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D61.82?
Clinical documentation must specify the nature of Myelophthisis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
